1. Home
  2. NTRB vs ONDS Comparison

NTRB vs ONDS Comparison

Compare NTRB & ONDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTRB
  • ONDS
  • Stock Information
  • Founded
  • NTRB 2016
  • ONDS 2014
  • Country
  • NTRB United States
  • ONDS United States
  • Employees
  • NTRB N/A
  • ONDS N/A
  • Industry
  • NTRB Industrial Specialties
  • ONDS Telecommunications Equipment
  • Sector
  • NTRB Health Care
  • ONDS Telecommunications
  • Exchange
  • NTRB Nasdaq
  • ONDS Nasdaq
  • Market Cap
  • NTRB 77.9M
  • ONDS N/A
  • IPO Year
  • NTRB N/A
  • ONDS N/A
  • Fundamental
  • Price
  • NTRB $4.08
  • ONDS $1.47
  • Analyst Decision
  • NTRB
  • ONDS Buy
  • Analyst Count
  • NTRB 0
  • ONDS 1
  • Target Price
  • NTRB N/A
  • ONDS $1.50
  • AVG Volume (30 Days)
  • NTRB 30.2K
  • ONDS 6.2M
  • Earning Date
  • NTRB 12-04-2024
  • ONDS 11-12-2024
  • Dividend Yield
  • NTRB N/A
  • ONDS N/A
  • EPS Growth
  • NTRB N/A
  • ONDS N/A
  • EPS
  • NTRB N/A
  • ONDS N/A
  • Revenue
  • NTRB $2,021,771.00
  • ONDS $8,024,937.00
  • Revenue This Year
  • NTRB N/A
  • ONDS N/A
  • Revenue Next Year
  • NTRB N/A
  • ONDS $255.67
  • P/E Ratio
  • NTRB N/A
  • ONDS N/A
  • Revenue Growth
  • NTRB N/A
  • ONDS N/A
  • 52 Week Low
  • NTRB $2.22
  • ONDS $0.54
  • 52 Week High
  • NTRB $9.60
  • ONDS $1.99
  • Technical
  • Relative Strength Index (RSI)
  • NTRB 40.82
  • ONDS 65.28
  • Support Level
  • NTRB $3.87
  • ONDS $1.06
  • Resistance Level
  • NTRB $4.80
  • ONDS $1.88
  • Average True Range (ATR)
  • NTRB 0.51
  • ONDS 0.27
  • MACD
  • NTRB 0.04
  • ONDS 0.06
  • Stochastic Oscillator
  • NTRB 21.21
  • ONDS 66.11

About NTRB Nutriband Inc.

Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.

Share on Social Networks: